8-KEarnings & ResultsExhibits & Filings

BRISTOL MYERS SQUIBB CO 8-K Report, Financial Results (Jan 24, 2014)

Filed January 24, 2014For Securities:BMYCELG-RIBMYMP

Summary

Bristol-Myers Squibb Company (BMY) has filed an 8-K report on January 24, 2014, to announce its financial results for the fourth quarter and full year of 2013. The report primarily serves to furnish a press release containing these results and supplemental information available on the company's website. Investors should refer to the furnished press release (Exhibit 99.1) and supplemental data (Exhibit 99.2) for detailed financial performance, operational updates, and forward-looking statements for the period ending December 31, 2013. While the 8-K itself does not contain the detailed financial figures, it directs investors to the primary sources of this critical information. These documents are expected to provide insights into revenue, profitability, drug pipeline developments, and any strategic announcements made by the company. Shareholders and potential investors are encouraged to review these exhibits to understand BMY's performance and outlook heading into 2014.

Key Highlights

  • 1BMY filed an 8-K on January 24, 2014, to report Q4 and Full Year 2013 financial results.
  • 2The report includes a press release (Exhibit 99.1) with the financial results.
  • 3Supplemental financial information is also furnished via Exhibit 99.2.
  • 4Investors are directed to these exhibits for detailed financial performance data.
  • 5The filing covers the period ending December 31, 2013.

Frequently Asked Questions

The actual financial results are located in the press release furnished as Exhibit 99.1 to this 8-K filing. Additional supplemental information is available as Exhibit 99.2 on the company's website.

The primary purpose of this 8-K filing is to officially announce and provide access to Bristol-Myers Squibb's financial results for the fourth quarter and the full twelve months of 2013, as well as any related supplemental information.

No, the 8-K filing itself does not contain the specific financial figures. It serves as a notification and directs investors to the attached press release (Exhibit 99.1) and supplemental information (Exhibit 99.2) where these details can be found.